Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cancer Stem Cell Vaccine in Nasopharyngeal Carcinoma
NCT02115958Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Mar 2014
- Primary completion
- May 2015
- Countries
- 1
01
Overview
Phase 2, randomised trial in nasopharyngeal carcinoma (NPC) (4 arms), sponsored by Fuda Cancer Hospital. Primary endpoint: Number of participants with adverse events at 3 months. Started Mar 2014; status: completed.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02115958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115958.